You Position: Home > Paper
玻璃体腔注射抗血管内皮生长因子药物治疗后黄斑裂孔17例临床观察
( views:43, downloads:22 )
- Author:
- No author available
- Journal Title:
- Chinese Journal of Ocular Fundus Diseases
- Issue:
- 9
- DOI:
- 10.3760/cma.j.cn511434-20200923-00465
- Key Word:
- 视网膜穿孔;血管生成抑制剂
Abstract： No abstract available
- [1]郑小燕,潘晓霞,靳翠.雷珠单抗联合眼底激光治疗视网膜分支静脉阻塞继发黄斑水肿的价值研究[J].2019,(17).
- [2]曾凤,卢亚梅,周元清,等.雷珠单抗联合微脉冲激光治疗视网膜分支静脉阻塞继发黄斑水肿的疗效观察[J].2020,(8).
- [3].Early-scatter laser photocoagulation promotes the formation of collateral vessels in branch retinal vein occlusion[J].2020,30(2).
- [4]Colin Siang Hui, Tan,Milton Cher Yong, Chew,Louis Wei Yi, Lim,etc.Advances in retinal imaging for diabetic retinopathy and diabetic macular edema.[J].2016.
- [5]Pielen, Amelie,Mirshahi, Alireza,Feltgen, Nicolas,etc.Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES): six-month results of a prospective randomized clinical trial[J].2015,93(1).
- [6]Pearce, Ian,Gekkieva, Margarita,Waldstein, Sebastian M.,etc.Individualized Stabilization Criteria-Driven Ranibizumab versus Laser in Branch Retinal Vein Occlusion Six-Month Results of BRIGHTER[J].2016,123(6).
- [7]Meyerle, Catherine,Shah, Syed Mahmood,He, Lingmin,etc.Changes in Retinal Nonperfusion Associated with Suppression of Vascular Endothelial Growth Factor in Retinal Vein Occlusion[J].2016,123(3).
- [8]Chhablani, J.,Narayanan, R.,Mathai, A.,etc.Combination of peripheral laser photocoagulation with intravitreal bevacizumab in naive eyes with macular edema secondary to CRVO: prospective randomized study[J].2016,30(7).
- [9]Hayashi A,Yunoki T,Yanagisawa S,etc.Intravitreal injection of bevacizumab combined with macular grid laser photocoagulation for macular edema in branch retinal vein occlusion.[J].2011,55(6).
- [10]Callizo, Josep,Atili, Abed,Striebe, Nina Antonia,etc.Bevacizumab versus bevacizumab and macular grid photocoagulation for macular edema in eyes with non-ischemic branch retinal vein occlusion: results from a prospective randomized study[J].2019,257(5).
- [11]Michael, Ip,Andrew, Hendrick.Retinal Vein Occlusion Review.[J].2017,(Spec ).
- [12]Siddhi.Goel,Atul.Kumar,Raghav.Ravani,etc.Comparison of ranibizumab alone versus ranibizumab with targeted retinal laser for branch retinal vein occlusion with macular edema[J].2019,67(7).
- [13]郭翠玲,陈得谜,王绍兰.不同方法治疗视网膜分支静脉阻塞继发黄斑水肿的疗效比较[J].2018,(10).
- [14]Farese,E.,Cennamo,G.,Velotti,N.,etc.Intravitreal bevacizumab combined with grid photocoagulation in recurrent macular edema secondary to retinal vein occlusion[J].2014,24(5).
- [15].PERIPHERAL ISCHEMIC RETINAL PHOTOCOAGULATION IN ADDITION TO INTRAVITREAL BEVACIZUMAB VERSUS INTRAVITREAL BEVACIZUMAB ALONE FOR THE TREATMENT OF MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION A Randomized Double-Masked Controlled Clinical Trial[J].2020,40(6).
- [16]Jaulim,A.,Ahmed,B.,Khanam,T.,etc.Branch retinal vein occlusion: Epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature[J].2013,33(5).
- [17]Stefansson E.Ocular oxygenation and the treatment of diabetic retinopathy.[J].2006,51(4).
- [18]Schmidt-Erfurth, Ursula,Garcia-Arumi, Jose,Gerendas, Bianca S.,etc.Guidelines for the Management of Retinal Vein Occlusion by the European Society of Retina Specialists (EURETINA)[J].2019,242(3).
- [19]Barosi,P.,Oum,M.A.,Azzolini,C.,etc.Combined intravitreal bevacizumab and grid laser photocoagulation for macular edema secondary to branch retinal vein occlusion[J].2012,22(4).
- [20]Campochiaro, Peter A.,Hafiz, Gulnar,Mir, Tahreem A.,etc.Scatter Photocoagulation Does Not Reduce Macular Edema or Treatment Burden in Patients with Retinal Vein Occlusion The RELATE Trial[J].2015,122(7).
- [21]Holz,F.G.,Roider,J.,Ogura,Y.,etc.VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-Month results of the phase III GALILEO study[J].2013,97(3).
- [22]A, Pierru,J-F, Girmens,E, Héron,etc.[Retinal vein occlusions].[J].2017,40(8).
- [23]Tomomatsu, Takeshi,Gozawa, Makoto,Tomomatsu, Yoko,etc.Comparative study of combined bevacizumab/targeted photocoagulation vs bevacizumab alone for macular oedema in ischaemic branch retinal vein occlusions[J].2016,94(3).
- [24]Prashant,Kumar,Yog Raj,Sharma,Parijat,Chandra,etc.Comparison of the Safety and Efficacy of Intravitreal Ranibizumab with or without Laser Photocoagulation Versus Dexamethasone Intravitreal Implant with or without Laser Photocoagulation for Macular Edema Secondary to Branch Retinal Vein Occlusion.[J].2019,61(2).
- [25]Bradshaw Steven E.,Gala Smeet,Nanavaty Merena,etc.Systematic literature review of treatments for management of complications of ischemic central retinal vein occlusion[J].2016,16(1).
- [26]Song Shuang,Yu Xiaobing,Zhang Peng,etc.Combination of Ranibizumab with macular laser for macular edema secondary to branch retinal vein occlusion: one-year results from a randomized controlled double-blind trial[J].2020,20(1).
- [27]Peter A. Campochiaro,Lloyd Paul Aiello,Philip J. Rosenfeld.Anti-Vascular Endothelial Growth Factor Agents in the Treatment of Retinal Disease: From Bench to Bedside[J].2016,(Supplement).
- [28]Matus Rehak,Eric Tilgner,Annegret Franke,etc.Early peripheral laser photocoagulation of nonperfused retina improves vision in patients with central retinal vein occlusion (Results of a proof of concept study).[J].2014,252(5).
- [29]Terashima, Hiroko,Hasebe, Hiruma,Okamoto, Fumiki,etc.Combination Therapy of Intravitreal Ranibizumab and Subthreshold Micropulse Photocoagulation for Macular Edema Secondary to Branch Retinal Vein Occlusion 6-Month Result[J].2019,39(7).
- [30]Cao, Wei,Cui, Hongping,Biskup, Ewelina.Combination of Grid Laser Photocoagulation and a Single Intravitreal Ranibizumab as an Efficient and Cost-Effective Treatment Option for Macular Edema Secondary to Branch Retinal Vein Occlusion[J].2019,22(4).
- [31]Jose S. Pulido,Christina J. Flaxel,Ron A. Adelman,etc.Retinal Vein Occlusions Preferred Practice Pattern® Guidelines[J].2016,(1).
- [32]Hidetaka Noma,Kanako Yasuda,Masahiko Shimura.Cytokines and the Pathogenesis of Macular Edema in Branch Retinal Vein Occlusion[J].2019,2019.